Hodgkin lymphoma and fulminant hepatic failure

被引:6
作者
Hong, Frank S. [1 ]
Smith, Carole L. [1 ]
Angus, Peter W. [2 ]
Crowley, Peter [3 ]
Ho, Wai Khoon [1 ]
机构
[1] Austin Hosp, Dept Haematol, Heidelberg, Vic 3084, Australia
[2] Austin Hosp, Dept Gastroenterol & Liver Transplantat, Heidelberg, Vic 3084, Australia
[3] Austin Hosp, Dept Anat Pathol, Heidelberg, Vic 3084, Australia
关键词
SINGLE-CENTER EXPERIENCE; ACUTE LIVER-FAILURE; DISEASE; MANIFESTATION;
D O I
10.3109/10428191003699571
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:947 / 951
页数:5
相关论文
共 16 条
[1]  
Abdulkader I, 2005, HEPATO-GASTROENTEROL, V52, P217
[2]  
Altintas A, 2008, Minerva Med, V99, P7
[3]   Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: Statistical analysis of all published cases and literature review [J].
Ballonoff, Ari ;
Kavanagh, Brian ;
Nash, Russell ;
Drabkin, Harry ;
Trotter, James ;
Costa, Luciano ;
Rabinovitch, Rachel .
ACTA ONCOLOGICA, 2008, 47 (05) :962-970
[4]   Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients [J].
Cervantes, F ;
Briones, J ;
Bruguera, M ;
Font, C ;
Grau, JM ;
Rozman, C ;
Montserrat, E .
ANNALS OF HEMATOLOGY, 1996, 72 (06) :357-360
[5]   Fulminant hepatic failure as a presenting paraneoplastic manifestation of Hodgkin's disease [J].
Dourakis, SP ;
Tzemanakis, E ;
Deutsch, M ;
Kafiri, G ;
Hadziyannis, SJ .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (09) :1055-1058
[6]   Hodgkin's disease with fulminant non-alcoholic steatohepatitis [J].
Kosmidou, IS ;
Aggarwal, A ;
Ross, JJ ;
Worthington, MG .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (10) :691-693
[7]  
LEFKOWITCH JH, 1985, ARCH PATHOL LAB MED, V109, P424
[8]   The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma [J].
Maeda, Lauren S. ;
Advani, Ranjana H. .
CURRENT OPINION IN ONCOLOGY, 2009, 21 (05) :397-400
[9]  
MAUCH PM, 1993, CANCER-AM CANCER SOC, V71, P2062, DOI 10.1002/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO
[10]  
2-0